Upstream Bio (UPB) Cash & Equivalents (2023 - 2026)
Upstream Bio's Cash & Equivalents came in at $79.4 million for Q2 2026, up 74.7% from $45.46 million a year earlier but down 17.9% from the prior quarter.
Powered by 
Analysis
Upstream Bio (UPB) Cash & Equivalents (2023 - 2026) Analysis & Trends
At the end of FY2025, Upstream Bio's Cash & Equivalents was $101.58 million, down 68.8% from FY2024.
- Going back by year, Cash & Equivalents was $325.89 million in FY2024 and $25.83 million in FY2023.
- The five-year range for quarterly Cash & Equivalents is $25.83 million (Q4 2023) to $325.89 million (Q4 2024).
- Year-over-year, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 36.1%.
- Business Quant data shows UPB's Cash & Equivalents at $96.72 million (Q1 2026), $101.58 million (Q4 2025) and $72.16 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Upstream Bio | 276.05 Mn | 276.05 Mn | -3.29 Mn | 79.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.40 Mn |
| Mar 31, 2026 | 96.72 Mn |
| Dec 31, 2025 | 101.58 Mn |
| Sep 30, 2025 | 72.16 Mn |
| Jun 30, 2025 | 45.46 Mn |
| Mar 31, 2025 | 71.31 Mn |
| Dec 31, 2024 | 325.89 Mn |
| Sep 30, 2024 | 32.95 Mn |
| Jun 30, 2024 | 47.34 Mn |
| Mar 31, 2024 | 31.51 Mn |
| Dec 31, 2023 | 25.83 Mn |
| Sep 30, 2023 | 47.32 Mn |
API Access
Upstream Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UPB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "UPB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UPB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();